Akorn, Inc.



$33.01Share Price
$4.1 BMarket Cap
4.4%EBIT / EV
4.3%FCF / EV
12.9%Cash ROIC
55.4%3yr Avg Revenue Growth
4.16Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

x mark The EBIT / Enterprise Value of 4.4% ranks as Below Average.
check mark The Free Cash Flow / Enterprise Value of 4.3% ranks as Average.
check mark The Return on Invested Capital Value of 13.2% ranks as Average.
check mark The Cash Return on Capital Value of 12.9% ranks as Above Average.
check mark The 3 Year Average Revenue Growth Value of 55.4% ranks as Very High.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 4.16.

Company Description

Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and prescription pharmaceuticals, as well as, animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health segments. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The Consumer Health segment engages in the sales of animal health and over-the-counter products, both branded and private label. The company was founded in 1971 and is headquartered in Lake Forest, IL.


You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
purple wand New Stocks Added!
orange wand New Stocks Added!